PresseBox - 330.754 Pressemitteilungen, 19.738 Pressefächer
PresseBox

prosthetic - Suchergebnis

Suche Detailsuche

Meldungen sortieren nachRelevanzMeldungsdatum

vorherige Seite vorherige Seite 12 nächste Seite nächste Seite
Ergebnisse 1 - 15 von 16
Nobel Biocare signs partnership agreement with Noritake

Nobel Biocare signs partnership agreement with Noritake

23.02.2010, 07:31 Uhr, Kooperationen / Fusionen, Nobel Biocare Deutschland GmbH

Nobel Biocare announced today that it has signed a preferred partnership agreement with the Japanese company Noritake Dental Supply Co., Limited, a leading supplier...

Nobel Biocare establishes Preferred Partner Program with Ivoclar Vivadent

Nobel Biocare establishes Preferred Partner Program with Ivoclar Vivadent

11.01.2010, 08:11 Uhr, Kooperationen / Fusionen, Nobel Biocare Deutschland GmbH

Nobel Biocare announced today that it has signed a preferred partnership agreement with Ivoclar Vivadent as part of a newly established Preferred Partner Program....

Nobel Biocare signs Preferred Partner Agreement with VITA

Nobel Biocare signs Preferred Partner Agreement with VITA

05.02.2010, 09:05 Uhr, Kooperationen / Fusionen, Nobel Biocare Deutschland GmbH

Nobel Biocare announced today that it has signed a preferred partnership agreement with Germanybased VITA Zahnfabrik, a global market leader in restorative and prosthetic...

Market stabilization confirmed

Market stabilization confirmed

10.02.2010, 08:36 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Reported revenue down 6.1% to EUR 581.4 million (CER minus 7.7%); revenues in line with markets - EMEA (excl. Spain) reports second consecutive quarterly revenue...

Market stabilization confirmed; Strong profitability and cash flow

Market stabilization confirmed; Strong profitability and cash flow

10.02.2010, 08:46 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Reported revenue down 6.1% to EUR 581.4 million (CER minus 7.7%); revenues in line with markets - EMEA (excl. Spain) reports second consecutive quarterly revenue...

Nobel Biocare acquires BioCad - a leading developer of computer-aided design software for prosthetics

Nobel Biocare acquires BioCad - a leading developer of computer-aided design software for prosthetics

11.11.2008, 10:32 Uhr, Software, Nobel Biocare Deutschland GmbH

Nobel Biocare announced today that it has signed an agreement to buy 100% of BioCad Medical Inc., a leading developer of computer-aided software for prosthetics,...

Product Initiatives

Product Initiatives

25.03.2009, 08:56 Uhr, FirmenIntern, Nobel Biocare Deutschland GmbH

At the 33rd IDS (International Dental Show), Nobel Biocare will globally launch its innovative state-of-the-art NobelProcera(TM) system with new prosthetic products...

Measuring Technology from Carl Zeiss Enables Perfect Fit of Dental Prosthetics

Measuring Technology from Carl Zeiss Enables Perfect Fit of Dental Prosthetics

03.03.2009, 16:41 Uhr, Optische Technologien, Carl Zeiss Industrielle Messtechnik GmbH

New implantology procedures for dental prosthetics should be applied as quickly as possible and with maximum precision. But just how accurately can implants be inserted?...

COLTENE acquires a stake in Brazilian company Vigodent

COLTENE acquires a stake in Brazilian company Vigodent

01.07.2009, 09:22 Uhr, FirmenIntern, Coltène/Whaledent AG

. -Acquisition of a 40% stake in Brazilian Company Vigodent including an option for the remaining 60% -Strengthening of the market position in Brazil and Latin...

Efficiency measures underpin margins amid continued challenging market environment; NobelProcera(TM)  launch on track

Efficiency measures underpin margins amid continued challenging market environment; NobelProcera(TM) launch on track

29.04.2009, 10:13 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Revenue growth in Q1 at constant exchange rates (CER) minus 9% at EUR 147.0 million - Reported revenue growth minus 5.5% - Unfavorable country mix, lower...

Half year 2009: Strong profitability; new products, technologies with continued success

Half year 2009: Strong profitability; new products, technologies with continued success

12.08.2009, 08:35 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Growth in line with market despite deferred scanner revenues and unfavorable country mix - Reported revenue growth minus 7.2% at EUR 300.4 million (CER minus...

Focus on business quality in a demanding market environment; revenue down 4%, cash flow up 26%

Focus on business quality in a demanding market environment; revenue down 4%, cash flow up 26%

11.02.2009, 09:42 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Revenue growth at constant exchange rates (CER) minus 4% at EUR 619.2 million - Change in commercial approach in Q4: reduced discounts and trade receivables -...

Analog Devices' iSensor multi-axis motion sensor wins 2008 elektra award as semicondutor product of the year

Analog Devices' iSensor multi-axis motion sensor wins 2008 elektra award as semicondutor product of the year

27.11.2008, 08:42 Uhr, Elektrotechnik, Analog Devices GmbH

Analog Devices, Inc. (ADI), a global leader in high performance semiconductors for signal processing applications, announced today that the ADIS16355 iSensor® multi-axis...

Profitabilität in schwierigem Umfeld gestärkt - neue Produkte und Technologien erfolgreich

Profitabilität in schwierigem Umfeld gestärkt - neue Produkte und Technologien erfolgreich

12.08.2009, 08:32 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Umsatz mit CHF 451.9 Mio. (EUR 300.4 Mio.) 7.2% unter Vergleichsniveau des Vorjahres (Umsatzrückgang in Lokalwährung minus 11.3%); - Umsatzentwicklung parallel...

NobelActive enjoys continued launch success; US/Western Europe sales and margins affected by economic environment; emerging countries continue strong growth

NobelActive enjoys continued launch success; US/Western Europe sales and margins affected by economic environment; emerging countries continue strong growth

03.11.2008, 09:58 Uhr, Finanzen / Bilanzen, Nobel Biocare Deutschland GmbH

. - Revenue growth at constant exchange rates (CER) minus 1% at EUR 456.6 million - Economic environment affected US and Western Europe sales and margin - Revenue...

vorherige Seite vorherige Seite 12 nächste Seite nächste Seite
Ergebnisse 1 - 15 von 16

Ähnliche Keywords

biocad optimet ophir

Pressearchiv

Ergebnis aus Gesamtarchiv Fehlertolerante Suche deaktivieren